This website is only directed at professional or qualified investors and is not suitable for retail or individual investors.

The information contained in this website is not for use within any country or jurisdiction or with any persons where such use would constitute a violation of law. This website is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security or investment or advisory service, or a recommendation of any such security or service. No representation is given that the products or services discussed on this website are suitable for any particular investor. If you are unsure about the meaning of this important information and/or your compliance with access limitations, please leave this website.

I understand this important information and would like to access the website

Our Products

Ruthenium Fund has three dedicated sub-funds running under its umbrella. Each sub-fund provides unique and very different investment propositions to comply to various goals and risk profiles of our clients.

People Behind the Fund

Ruthenium Fund is managed by the team of experienced professionals in financial markets, healthcare industry and investment infrastructure.

Contacts

5, allée Scheffer, Luxembourg, L - 2520 Luxembourg

Tel. : +352 262 649 6042

Mail : contact@ruthenium.fund

Investment solutions and infrastructure services for professional investors

Ruthenium Fund is an investment company incorporated in Luxembourg in 2015

© 2025 Ruthenium Fund S.A.

Capitalizing on our deep understanding of global pharmaceutical market, we developed a strategy focused on investments in pharmaceutical and biotechnology sectors through customized structured products. Fund aims to generate high long-term returns consistent with preservation of capital.

Fixed-income product with higher degree of flexibility. The Fund investment strategy focuses on hard currency denominated sovereign and corporate bonds across developed and emerging markets to diversify risk.

Ruthenium Fund S.A. SICAV-RAIF

Balanced investment product, which adheres to opportunistic multi-asset investment approach. Seeking to achieve sustainable positive return going through all stages of a market cycle, we use a combination of traditional assets and investment strategies based on derivatives.

Ruthenium Fund S.A. SICAV-RAIF

Denis Semenovykh

Board Member

Kirill Syrov

Board Member

Dmitry Reykhart

PhD, Chairman of the Board

Maxim Popov

Board Member

Timur Salikov

CFA, Board Member